Abstract
EphB receptor tyrosine kinases control multiple steps in nervous system development. However, it remains unclear whether EphBs regulate these different developmental processes directly or indirectly. In addition, given that EphBs signal through multiple mechanisms, it has been challenging to define which signaling functions of EphBs regulate particular developmental events. To address these issues, we engineered triple knock-in mice in which the kinase activity of three neuronally expressed EphBs can be rapidly, reversibly and specifically blocked. We found that the tyrosine kinase activity of EphBs was required for axon guidance in vivo. In contrast, EphB-mediated synaptogenesis occurred normally when the kinase activity of EphBs was inhibited, suggesting that EphBs mediate synapse development by an EphB tyrosine kinase–independent mechanism. Taken together, our data indicate that EphBs control axon guidance and synaptogenesis by distinct mechanisms and provide a new mouse model for dissecting EphB function in development and disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Klein, R. Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr. Opin. Cell Biol. 16, 580–589 (2004).
Lai, K.O. & Ip, N.Y. Synapse development and plasticity: roles of ephrin/Eph receptor signaling. Curr. Opin. Neurobiol. 19, 275–283 (2009).
Genander, M. & Frisen, J. Ephrins and Eph receptors in stem cells and cancer. Curr. Opin. Cell Biol. 22, 611–616 (2010).
Sanders, S.J. et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 485, 237–241 (2012).
Merlos-Suárez, A. & Batlle, E. Eph-ephrin signaling in adult tissues and cancer. Curr. Opin. Cell Biol. 20, 194–200 (2008).
Pasquale, E.B. Eph receptors and ephrins in cancer: bidirectional signaling and beyond. Nat. Rev. Cancer 10, 165–180 (2010).
Cissé, M. et al. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature 469, 47–52 (2011).
Sheffler-Collins, S.I. & Dalva, M.B. EphBs: an integral link between synaptic function and synaptopathies. Trends Neurosci. 35, 293–304 (2012).
Henkemeyer, M. et al. Nuk controls pathfinding of commissural axons in the mammalian central nervous system. Cell 86, 35–46 (1996).
Grunwald, I.C. et al. Kinase-independent requirement of EphB2 receptors in hippocampal synaptic plasticity. Neuron 32, 1027–1040 (2001).
Henderson, J.T. et al. The receptor tyrosine kinase EphB2 regulates NMDA-dependent synaptic function. Neuron 32, 1041–1056 (2001).
Kayser, M.S., Nolt, M.J. & Dalva, M.B. EphB receptors couple dendritic filopodia motility to synapse formation. Neuron 59, 56–69 (2008).
Kayser, M.S., McClelland, A.C., Hughes, E.G. & Dalva, M.B. Intracellular and trans-synaptic regulation of glutamatergic synaptogenesis by EphB receptors. J. Neurosci. 26, 12152–12164 (2006).
Himanen, J.P., Saha, N. & Nikolov, D.B. Cell-cell signaling via Eph receptors and ephrins. Curr. Opin. Cell Biol. 19, 534–542 (2007).
Dalva, M.B. et al. EphB receptors interact with NMDA receptors and regulate excitatory synapse formation. Cell 103, 945–956 (2000).
Nolt, M.J. et al. EphB controls NMDA receptor function and synaptic targeting in a subunit-specific manner. J. Neurosci. 31, 5353–5364 (2011).
Palmer, A. et al. EphrinB phosphorylation and reverse signaling: regulation by Src kinases and PTP-BL phosphatase. Mol. Cell 9, 725–737 (2002).
Henkemeyer, M., Itkis, O.S., Ngo, M., Hickmott, P.W. & Ethell, I.M. Multiple EphB receptor tyrosine kinases shape dendritic spines in the hippocampus. J. Cell Biol. 163, 1313–1326 (2003).
Orioli, D., Henkemeyer, M., Lemke, G., Klein, R. & Pawson, T. Sek4 and Nuk receptors cooperate in guidance of commissural axons and in palate formation. EMBO J. 15, 6035–6049 (1996).
O'Donnell, M., Chance, R.K. & Bashaw, G.J. Axon growth and guidance: receptor regulation and signal transduction. Annu. Rev. Neurosci. 32, 383–412 (2009).
Cowan, C.A. et al. Ephrin-B2 reverse signaling is required for axon pathfinding and cardiac valve formation, but not early vascular development. Dev. Biol. 271, 263–271 (2004).
Mendes, S.W., Henkemeyer, M. & Liebl, D.J. Multiple Eph receptors and B-class ephrins regulate midline crossing of corpus callosum fibers in the developing mouse forebrain. J. Neurosci. 26, 882–892 (2006).
Petros, T.J., Shrestha, B.R. & Mason, C. Specificity and sufficiency of EphB1 in driving the ipsilateral retinal projection. J. Neurosci. 29, 3463–3474 (2009).
Chenaux, G. & Henkemeyer, M. Forward signaling by EphB1/EphB2 interacting with ephrin-B ligands at the optic chiasm is required to form the ipsilateral projection. Eur. J. Neurosci. 34, 1620–1633 (2011).
Ethell, I.M. et al. EphB/syndecan-2 signaling in dendritic spine morphogenesis. Neuron 31, 1001–1013 (2001).
Bishop, A.C. et al. A chemical switch for inhibitor-sensitive alleles of any protein kinase. Nature 407, 395–401 (2000).
Blethrow, J., Zhang, C., Shokat, K.M. & Weiss, E.L. Design and use of analog-sensitive protein kinases. Curr. Protoc. Mol. Biol. 18, 18.11 (2004).
Chen, X. et al. A chemical-genetic approach to studying neurotrophin signaling. Neuron 46, 13–21 (2005).
Bishop, A.C. et al. Design of allele-specific inhibitors to probe protein kinase signaling. Curr. Biol. 8, 257–266 (1998).
Alaimo, P.J., Shogren-Knaak, M.A. & Shokat, K.M. Chemical genetic approaches for the elucidation of signaling pathways. Curr. Opin. Chem. Biol. 5, 360–367 (2001).
Rozakis-Adcock, M., Fernley, R., Wade, J., Pawson, T. & Bowtell, D. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. Nature 363, 83–85 (1993).
Moeller, M.L., Shi, Y., Reichardt, L.F. & Ethell, I.M. EphB receptors regulate dendritic spine morphogenesis through the recruitment/phosphorylation of focal adhesion kinase and RhoA activation. J. Biol. Chem. 281, 1587–1598 (2006).
Torres, R. et al. PDZ proteins bind, cluster, and synaptically colocalize with Eph receptors and their ephrin ligands. Neuron 21, 1453–1463 (1998).
Chumley, M.J., Catchpole, T., Silvany, R.E., Kernie, S.G. & Henkemeyer, M. EphB receptors regulate stem/progenitor cell proliferation, migration, and polarity during hippocampal neurogenesis. J. Neurosci. 27, 13481–13490 (2007).
Yucel, S., Dravis, C., Garcia, N., Henkemeyer, M. & Baker, L.A. Hypospadias and anorectal malformations mediated by Eph/ephrin signaling. J. Pediatr. Urol. 3, 354–363 (2007).
Risley, M., Garrod, D., Henkemeyer, M. & McLean, W. EphB2 and EphB3 forward signalling are required for palate development. Mech. Dev. 126, 230–239 (2009).
Choi, Y. et al. Discovery and structural analysis of Eph receptor tyrosine kinase inhibitors. Bioorg. Med. Chem. Lett. 19, 4467–4470 (2009).
Qiu, R. et al. Regulation of neural progenitor cell state by ephrin-B. J. Cell Biol. 181, 973–983 (2008).
Cowan, C.W. et al. Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron 46, 205–217 (2005).
Williams, S.E. et al. Ephrin-B2 and EphB1 mediate retinal axon divergence at the optic chiasm. Neuron 39, 919–935 (2003).
Luria, V., Krawchuk, D., Jessell, T.M., Laufer, E. & Kania, A. Specification of motor axon trajectory by ephrin-B:EphB signaling: symmetrical control of axonal patterning in the developing limb. Neuron 60, 1039–1053 (2008).
Williams, S.E., Mason, C.A. & Herrera, E. The optic chiasm as a midline choice point. Curr. Opin. Neurobiol. 14, 51–60 (2004).
Bush, J.O. & Soriano, P. Ephrin-B1 regulates axon guidance by reverse signaling through a PDZ-dependent mechanism. Genes Dev. 23, 1586–1599 (2009).
Takasu, M.A., Dalva, M.B., Zigmond, R.E. & Greenberg, M.E. Modulation of NMDA receptor–dependent calcium influx and gene expression through EphB receptors. Science 295, 491–495 (2002).
McClelland, A.C., Sheffler-Collins, S.I., Kayser, M.S. & Dalva, M.B. Ephrin-B1 and ephrin-B2 mediate EphB-dependent presynaptic development via syntenin-1. Proc. Natl. Acad. Sci. USA 106, 20487–20492 (2009).
Holmberg, J. & Frisen, J. Ephrins are not only unattractive. Trends Neurosci. 25, 239–243 (2002).
Moon, M.S. & Gomez, T.M. Balanced Vav2 GEF activity regulates neurite outgrowth and branching in vitro and in vivo. Mol. Cell. Neurosci. 44, 118–128 (2010).
Banko, M.R. et al. Chemical genetic screen for AMPKα2 substrates uncovers a network of proteins involved in mitosis. Mol. Cell 44, 878–892 (2011).
Knight, Z.A. & Shokat, K.M. Chemical genetics: where genetics and pharmacology meet. Cell 128, 425–430 (2007).
Batlle, E. et al. EphB receptor activity suppresses colorectal cancer progression. Nature 435, 1126–1130 (2005).
Petros, T.J., Bryson, J.B. & Mason, C. Ephrin-B2 elicits differential growth cone collapse and axon retraction in retinal ganglion cells from distinct retinal regions. Dev. Neurobiol. 70, 781–794 (2010).
Plump, A.S. et al. Slit1 and Slit2 cooperate to prevent premature midline crossing of retinal axons in the mouse visual system. Neuron 33, 219–232 (2002).
Xu-Friedman, M.A. & Regehr, W.G. Presynaptic strontium dynamics and synaptic transmission. Biophys. J. 76, 2029–2042 (1999).
Acknowledgements
We thank M. Thompson, Y. Zhou and H. Ye of the Children's Hospital Boston Intellectual and Developmental Disabilities Research Center Mouse Gene Manipulation Core for ES cell work and blastocyst injection, T. Kuwajima and members of C. Mason's laboratory for advice on retinal explants and DiI labeling, M. Lopez for help selecting and generating PP1 analogs, Z. Wills and A. Mardinly for help with synapse analysis, S. Cohen for advice on electrophysiological recordings, P. Zhang for assistance with animal management, and L. Hu for antibody work. This research was funded by US National Institutes of Health grants RO1-NS-045500 (M.E.G.) and RO1-EY-018207 (C.W.C.). H.-Y.H.H. was supported by the Marion Abbe Fellowship of the Damon Runyon Cancer Research Foundation and US National Institutes of Health training grants in neurodegeneration and cancer biology. M.J.S. was supported by a National Science Foundation Graduate Research Fellowship. M.A.R. was supported by a training grant from the National Institute on Drug Abuse (T32 DA07290).
Author information
Authors and Affiliations
Contributions
M.J.S., H.-Y.H.H. and M.E.G. conceived and designed the study. M.J.S. and H.-Y.H.H conducted all of the experiments unless otherwise noted. B.L.B. and N.S. performed electrophysiological recordings. J.Z. generated EphB1 and EphB3 targeting constructs. M.A.R. and C.W.C. contributed to the axon guidance experiments. A.N.M. and A.A.R. generated shRNAs for EphBs. B.A. performed qPCR experiments. C.Z. and K.M.S. designed and synthesized inhibitors. M.J.S., H.-Y.H.H. and M.E.G. wrote the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Figures 1–7 and Supplementary Table 1 (PDF 3842 kb)
Rights and permissions
About this article
Cite this article
Soskis, M., Ho, HY., Bloodgood, B. et al. A chemical genetic approach reveals distinct EphB signaling mechanisms during brain development. Nat Neurosci 15, 1645–1654 (2012). https://doi.org/10.1038/nn.3249
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nn.3249
This article is cited by
-
Mechanisms of ephrin–Eph signalling in development, physiology and disease
Nature Reviews Molecular Cell Biology (2016)